KPNB1 and cancer: To identify whether overexpression of Kpnβ1 resulted in any changes to the cancer cell response to cisplatin treatment, HeLa EGFP and Kpnβ1-EGFP cells were treated with cisplatin and the effects on various processes observed, including cell viability and apoptosis.